According to scPharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.97.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 6.04 | 79.22% |
2022-12-31 | 3.37 | 38.56% |
2021-12-31 | 2.43 | 38.29% |
2020-12-31 | 1.76 | -17.79% |
2019-12-31 | 2.14 | 141.33% |
2018-12-31 | 0.8867 | -55.86% |
2017-12-31 | 2.01 | |
2016-12-31 | N/A |